In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
May 16th, 2008 | 23 | Yes |
Popular Name: Merck 5 Merck 5
Find On: PubMed — Wikipedia — Google
CAS Numbers: 457081-03-7 , [457081-03-7]
2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE
2-(tert-butyl)-9-fluoro-3H-benzo[h]imidazo[4,5-f]isoquinolin-7(6H)-one
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.03 | 7.37 | -15.5 | 2 | 4 | 0 | 62 | 309.344 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 7.47e-03 g/l | DrugBank-experimental |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDK2-4-E | Cyclin-dependent Kinase 2 (cluster #4 Of 5), Eukaryotic | Eukaryotes | 3300 | 0.33 | Binding ≤ 10μM |
CSK-1-E | Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.35 | Binding ≤ 10μM |
FER-1-E | Tyrosine-protein Kinase FER (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.55 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1480 | 0.35 | Binding ≤ 10μM |
FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.37 | Binding ≤ 10μM |
FGFR3-1-E | Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1480 | 0.35 | Binding ≤ 10μM |
FGFR4-1-E | Fibroblast Growth Factor Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1480 | 0.35 | Binding ≤ 10μM |
FYN-1-E | Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic | Eukaryotes | 500 | 0.38 | Binding ≤ 10μM |
HCK-1-E | Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7700 | 0.31 | Binding ≤ 10μM |
IKKB-1-E | Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 300 | 0.40 | Binding ≤ 10μM |
JAK1-1-E | Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 15 | 0.48 | Binding ≤ 10μM |
JAK2-1-E | Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.55 | Binding ≤ 10μM |
JAK3-2-E | Tyrosine-protein Kinase JAK3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5 | 0.51 | Binding ≤ 10μM |
KAP3-1-E | CAMP-dependent Protein Kinase Type II-beta Regulatory Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7100 | 0.31 | Binding ≤ 10μM |
KAPCA-2-E | CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #2 Of 4), Eukaryotic | Eukaryotes | 7100 | 0.31 | Binding ≤ 10μM |
KAPCB-2-E | CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit (cluster #2 Of 3), Eukaryotic | Eukaryotes | 7100 | 0.31 | Binding ≤ 10μM |
KAPCG-1-E | CAMP-dependent Protein Kinase, Gamma Catalytic Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7100 | 0.31 | Binding ≤ 10μM |
KPCA-6-E | Protein Kinase C Alpha (cluster #6 Of 6), Eukaryotic | Eukaryotes | 1200 | 0.36 | Binding ≤ 10μM |
MP2K1-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 160 | 0.41 | Binding ≤ 10μM |
MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 160 | 0.41 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1490 | 0.35 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1490 | 0.35 | Binding ≤ 10μM |
TYK2-1-E | Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.55 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1520 | 0.35 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.36 | Binding ≤ 10μM |
VGFR3-1-E | Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 690 | 0.38 | Binding ≤ 10μM |
JAK1-1-E | Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 52 | 0.44 | Functional ≤ 10μM |
JAK3-1-E | Tyrosine-protein Kinase JAK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 52 | 0.44 | Functional ≤ 10μM |
Z104300-1-O | Mitogen-activated Protein Kinase; ERK1/ERK2 (cluster #1 Of 1), Other | Other | 1780 | 0.35 | Binding ≤ 10μM |
Z80109-2-O | CTLL (Cytotoxic T-cells) (cluster #2 Of 2), Other | Other | 52 | 0.44 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 160 | 0.41 | Binding ≤ 1μM |
MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 160 | 0.41 | Binding ≤ 1μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 940 | 0.37 | Binding ≤ 1μM |
IKKB_HUMAN | O14920 | Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit, Human | 300 | 0.40 | Binding ≤ 1μM |
FER_HUMAN | P16591 | Tyrosine-protein Kinase FER, Human | 1 | 0.55 | Binding ≤ 1μM |
FYN_HUMAN | P06241 | Tyrosine-protein Kinase FYN, Human | 500 | 0.38 | Binding ≤ 1μM |
JAK1_MOUSE | P52332 | Tyrosine-protein Kinase JAK1, Mouse | 15 | 0.48 | Binding ≤ 1μM |
JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 15 | 0.48 | Binding ≤ 1μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1 | 0.55 | Binding ≤ 1μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 5 | 0.51 | Binding ≤ 1μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 1 | 0.55 | Binding ≤ 1μM |
VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 690 | 0.38 | Binding ≤ 1μM |
KAPCA_HUMAN | P17612 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Human | 7100 | 0.31 | Binding ≤ 10μM |
KAPCB_HUMAN | P22694 | CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit, Human | 7100 | 0.31 | Binding ≤ 10μM |
KAP3_BOVIN | P31322 | CAMP-dependent Protein Kinase Type II-beta Regulatory Subunit, Bovin | 7100 | 0.31 | Binding ≤ 10μM |
KAPCG_HUMAN | P22612 | CAMP-dependent Protein Kinase, Gamma Catalytic Subunit, Human | 7100 | 0.31 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 3300 | 0.33 | Binding ≤ 10μM |
MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 160 | 0.41 | Binding ≤ 10μM |
MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 160 | 0.41 | Binding ≤ 10μM |
FGFR1_MOUSE | P16092 | Fibroblast Growth Factor Receptor 1, Mouse | 1480 | 0.35 | Binding ≤ 10μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 1480 | 0.35 | Binding ≤ 10μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 1480 | 0.35 | Binding ≤ 10μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 1480 | 0.35 | Binding ≤ 10μM |
FGFR4_HUMAN | P22455 | Fibroblast Growth Factor Receptor 4, Human | 1480 | 0.35 | Binding ≤ 10μM |
IKKB_HUMAN | O14920 | Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit, Human | 300 | 0.40 | Binding ≤ 10μM |
Z104300 | Z104300 | Mitogen-activated Protein Kinase; ERK1/ERK2 | 1780 | 0.35 | Binding ≤ 10μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 1490 | 0.35 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 1490 | 0.35 | Binding ≤ 10μM |
KPCA_HUMAN | P17252 | Protein Kinase C Alpha, Human | 1200 | 0.36 | Binding ≤ 10μM |
CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 2100 | 0.35 | Binding ≤ 10μM |
FER_HUMAN | P16591 | Tyrosine-protein Kinase FER, Human | 1 | 0.55 | Binding ≤ 10μM |
FYN_HUMAN | P06241 | Tyrosine-protein Kinase FYN, Human | 500 | 0.38 | Binding ≤ 10μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 7700 | 0.31 | Binding ≤ 10μM |
JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 15 | 0.48 | Binding ≤ 10μM |
JAK1_MOUSE | P52332 | Tyrosine-protein Kinase JAK1, Mouse | 15 | 0.48 | Binding ≤ 10μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1 | 0.55 | Binding ≤ 10μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 5 | 0.51 | Binding ≤ 10μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 1 | 0.55 | Binding ≤ 10μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 1520 | 0.35 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 1400 | 0.36 | Binding ≤ 10μM |
VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 690 | 0.38 | Binding ≤ 10μM |
Z80109 | Z80109 | CTLL (Cytotoxic T-cells) | 100 | 0.43 | Functional ≤ 10μM |
JAK1_MOUSE | P52332 | Tyrosine-protein Kinase JAK1, Mouse | 100 | 0.43 | Functional ≤ 10μM |
JAK3_MOUSE | Q62137 | Tyrosine-protein Kinase JAK3, Mouse | 100 | 0.43 | Functional ≤ 10μM |
Description | Species |
---|---|
Acetylcholine regulates insulin secretion | |
Activated point mutants of FGFR2 | |
Activation of ATR in response to replication stress | |
Activation of NF-kappaB in B cells | |
Activation of the pre-replicative complex | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
betaKlotho-mediated ligand binding | |
Ca2+ pathway | |
Calmodulin induced events | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Cell surface interactions at the vascular wall | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation through the activation of Adenylate Cyclase | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
DAP12 signaling | |
DARPP-32 events | |
DCC mediated attractive signaling | |
Depolymerisation of the Nuclear Lamina | |
Disinhibition of SNARE formation | |
DNA Damage/Telomere Stress Induced Senescence | |
Downstream signal transduction | |
Downstream TCR signaling | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK1 activation | |
ERK2 activation | |
Factors involved in megakaryocyte development and platelet production | |
FCERI mediated NF-kB activation | |
FCGR activation | |
FGFR1c and Klotho ligand binding and activation | |
FGFR1c ligand binding and activation | |
FGFR4 ligand binding and activation | |
FRS2-mediated cascade | |
G alpha (z) signalling events | |
G0 and Early G1 | |
G2 Phase | |
GAB1 signalosome | |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | |
Gluconeogenesis | |
GPVI-mediated activation cascade | |
Growth hormone receptor signaling | |
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |
HuR stabilizes mRNA | |
IKK complex recruitment mediated by RIP1 | |
Inactivation, recovery and regulation of the phototransduction cascade | |
Integrin alphaIIb beta3 signaling | |
Integrin cell surface interactions | |
Interferon alpha/beta signaling | |
Interferon gamma signaling | |
Interleukin receptor SHC signaling | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-6 signaling | |
Interleukin-7 signaling | |
IRAK1 recruits IKK complex | |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | |
ISG15 antiviral mechanism | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
Meiotic recombination | |
MEK activation | |
NCAM signaling for neurite out-growth | |
Nef and signal transduction | |
Negative regulation of FGFR signaling | |
Nephrin interactions | |
Netrin mediated repulsion signals | |
Neurophilin interactions with VEGF and VEGFR | |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | |
NF-kB is activated and signals survival | |
NOD1/2 Signaling Pathway | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
p75NTR recruits signalling complexes | |
PD-1 signaling | |
PECAM1 interactions | |
Phospholipase C-mediated cascade | |
Phosphorylation of CD3 and TCR zeta chains | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
PI-3K cascade | |
PI3K Cascade | |
PIP3 activates AKT signaling | |
PKA activation | |
PKA activation in glucagon signalling | |
PKA-mediated phosphorylation of CREB | |
PKA-mediated phosphorylation of key metabolic factors | |
Platelet Adhesion to exposed collagen | |
Prolactin receptor signaling | |
RAF phosphorylates MEK | |
Rap1 signalling | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of IFNA signaling | |
Regulation of IFNG signaling | |
Regulation of insulin secretion | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Response to elevated platelet cytosolic Ca2+ | |
RIP-mediated NFkB activation via ZBP1 | |
RMTs methylate histone arginines | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Sema3A PAK dependent Axon repulsion | |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | |
Senescence-Associated Secretory Phenotype (SASP) | |
SHC-mediated cascade | |
Signal transduction by L1 | |
Signaling by activated point mutants of FGFR1 | |
Signaling by activated point mutants of FGFR3 | |
Signaling by ERBB2 | |
Signaling by FGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR1 amplification mutants | |
Signaling by FGFR2 amplification mutants | |
Signaling by FGFR3 mutants | |
Signaling by FGFR4 mutants | |
Signaling by Leptin | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
Syndecan interactions | |
t(4;14) translocations of FGFR3 | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
TRAF6 mediated NF-kB activation | |
Trafficking of GluR2-containing AMPA receptors | |
Uptake and function of anthrax toxins | |
Vasopressin regulates renal water homeostasis via Aquaporins | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation | |
WNT5A-dependent internalization of FZD4 |
No pre-computed analogs available. Try a structural similarity search.